Estimation of renal function in lung cancer patients

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 397-402

  Trobec, Katja ^a   Knez, Lea ^a   Meško Brguljan, Pika ^a   Cufer, Tanja ^a   Lainščak, Mitja ^a,b  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CKD EPI equation; Cockcroft Gault equation; Glomerular filtration rate; Lung cancer; MDRD equation; Wright equation

Indexed keywords

CREATININE;

ACCURACY; ADULT; AGED; ARTICLE; BODY MASS; BODY SURFACE; BODY WEIGHT; CALCULATION; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COCKCROFT GAULT EQUATION; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION TEST; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; MODIFICATION OF DIET IN RENAL DISEASE EQUATION ADJUSTED FOR BODY SURFACE AREA EQUATION; PERFORMANCE; PRIORITY JOURNAL; WRIGHT EQUATION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BODY SURFACE AREA; BODY WEIGHT; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 84860534203     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.016     Document Type: Article

References (29)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
2. Crinò L., Weder W., van Meerbeeck J., Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Ann Oncol 2010, 21:v103-v115.
3. Addario G.D., Früh M., Baumann P., Klepetko W., Felip E. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21:v116-v119.
4. Sørensen M., Pijls-johannesma M., Felip E. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21:v120-v125.
5. Launay-Vacher V., Etessami R., Janus N., Spano J.P., Ray-Coquard I., Oudard S., et al. Renal Insufficiency Anticancer Medications (IRMA) Study Group. Lung cancer and renal insufficiency: prevalence and anticancer drug issues. Lung 2009, 187(1):69-74.
6. Calvert A.H. Carboplatin dosage: prospective evaluation of a simple equation based on renal function. J Clin Oncol 1989, 7:1748-1756.
7. Hanigan M.H., Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 2003, 1:47-61.
8. Hubner R.A., Goldstein R., Mitchell S., Jones A., Ashley S., O'Brien M.E., et al. Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy. Lung Cancer 2011, doi:10.1016/j.lungcan.2011.01.013 [E-published ahead of print].
9. Chang G.C., Yang T.Y., Shih C.M., Lin L.Y., Lee H.S., Chiang C.D. Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cancer receiving cisplatin-based chemotherapy. J Formos Med Assoc 2003, 102:257-261.
10. Camara A.A., Arn K.D., Reimer A., Newburgh L.H. The twenty fourly ECC as a clinical measure of the functional state of the kidneys. J Lab Clin Med 1951, 37:743-763.
11. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002, 39:S1-S266.
12. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
13. Wright J.G., Boddy A.V., Highley M., Fenwick J., McGill A., Calvert A.H. Estimates of glomerular filtration rate in cancer patients. Brit J Cancer 2001, 84:452-459.
14. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
15. National Kidney Disease Epidemiology Group. Laboratory Professionals: estimating GFR. [accessed 25.01.11]. http://www.nkdep.nih.gov/.labprofessionals/estimating_gfr.htm%23mdrd.
16. National Kidney Disease Epidemiology Group. Chronic Kidney Disease and Drug Dosing: Information for Providers. [accessed 15.07.11]. http://www.nkdep.nih.gov/professionals/drug-dosing-information.htm.
17. Levey A.S., Lesley A.S., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
18. Faluyi O.O., Masinhghe S.P., Hayward R.L. Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in oncology patients with renal impairment. Med Oncol 2011, doi:10.1007/s12032-011-9824-0 [E-published ahead of print].
19. Hahn T., Yao S., Dunford L.M., Thomas J., Lohr J., Arora P., et al. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT. Biol Blood Marrow Transplant 2009, 15:574-579.
20. Marx G.M., Blake G.M., Galani E., Steer C.B., Harper S.E., adamson K.L., et al. Evaluation of the Crockcroft-Gault, Jeliffe and Wright equatione in estimating renal function in elderly cancer patients. Ann Oncol 2004, 15:291-295.
21. Poole S.G., Dooley M.J., Rischin D. a comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients. Ann Oncol 2002, 13:399-402.
22. de Lemos M.L., Hsieh T., Hamata L., Levin A., Swenerton K., Djurdjev O., et al. Evaluation of predictive equatione for glomerular filtration rate for carboplatin dosing in gynaecological malignancies. Gynaecol Oncol 2006, 103:1063-1069.
23. Barraclough L.H., Field C., Wieringa g, Swindell R., Livsey J.E., Davidson S.E. Estimation of renal function-what is appropriate in cancer patients?. Clin Oncol 2008, 20:721-726.
24. Florkowski C.M., Chew-Harris J.S.C. Methods of estimating GFR-different equations including CKD-EPI. Clin Biochem Rev 2011, 32:75-79.
25. Jones G.R.D. Estimating renal function for drug dosing decisions. Clin Biochem Rev 2011, 32:81-88.
26. von Haehling S., Anker S.D. Cachexia as a major underestimated and unmet edical need: facts and numbers. J Cachex Sarcopenia Muscle 2010, 1:1-5.
27. Argilés J.M., López-Soriano F.J., Toledo M., Betancourt A., Serpe R., Busquets S. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachex Sarcopenia Muscle 2011, 2:87-93.
28. Rosseau M.C., Parent M.E., Siemiatycki J. Comparison of self-reported height and weight by cancer type among men from Montreal, Canada. Eur J Cancer Prev 2005, 14:431-438.
29. Baracos V.E., Reiman T., Mourtzakis M., Gioulbasanis I., Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010, 91:1133S-1137S. doi:10.3945/ajcn.2010.28608C [E-published].